Dental and medical products company Henry Schein (NASDAQ:HSIC) missed Wall Street’s revenue expectations in Q4 CY2024, but sales rose 5.8% year on year to $3.19 billion. Its non-GAAP profit of $1.19 per share was 1.6% below analysts’ consensus estimates.
(Bloomberg) -- There’s growing “suspicion” among investors about the scope for more S&P 500 gains at a time when European and Chinese stocks are outperforming, according to Bank of America Corp. strategist Michael Hartnett.Most Read from BloombergTrump Targets $128 Billion California High-Speed Rail ProjectTrump Asserts Power Over NYC, Proclaims ‘Long Live the King’NYC’s Congestion Pricing Pulls In $48.6 Million in First MonthNYC to Shut Migrant Center in Former Hotel as Crisis EasesAs Visitors
Medical device company Integra LifeSciences (NASDAQ:IART) missed Wall Street’s revenue expectations in Q4 CY2024, but sales rose 11.5% year on year to $442.6 million. Next quarter’s revenue guidance of $380 million underwhelmed, coming in 7.7% below analysts’ estimates. Its non-GAAP profit of $0.97 per share was 13.5% above analysts’ consensus estimates.
Money market account interest rates today are still well above historical norms. Find out where to get the best money market account rates now.
Tariffs and governmental uncertainty have been at the forefront of investors' minds. But while they may be factors, they may also be covering up for something a little more basic — and just as powerful.
A buy-the-dip approach is bolstering the chip maker as individual investors position for its shares to rally.
“Congestion pricing” is the stuffy-sounding name of a New York policy that is, by every available metric, a resounding success. Anyone, including lapsed New Yorker President Trump, saying otherwise is simply ignoring the evidence.
Dell Technologies is expected to report fiscal 2025 fourth-quarter results after markets close Thursday, with analysts calling for revenue growth driven by servers and networking solutions.
As the Q4 earnings season wraps, let’s dig into this quarter’s best and worst performers in the air freight and logistics industry, including FedEx (NYSE:FDX) and its peers.
The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take a look at how household products stocks fared in Q4, starting with Central Garden & Pet (NASDAQ:CENT).